Minerva medica
-
Letter Randomized Controlled Trial
Clinical study on prevention and treatment of perioperative myocardial injury and cardiac function by xuemaitong II granule.
-
Letter Randomized Controlled Trial
Effect of psychological nursing on postoperative complications and negative emotion in patients with non-small cell lung cancer.
-
Letter Randomized Controlled Trial
Study on the relieving effect of evidence-based nursing model on pain nursing of patients after liver transplantation.
-
Severe asthma (SA) in an asthma that requires therapy with high dose inhaled corticosteroids with a second controller, or oral corticosteroids, to ensure that it does not become "uncontrolled," or that it does not respond to appropriate therapy. Severe asthma has a great impact on quality of life. ⋯ Specific registers of SA, both national and international, are really important to describe the epidemiological characteristics of the disease and to analyze the clinical characteristics of the various subgroups of patients. This is an excellent starting point to be able to investigate the characteristics of the disease in detail.
-
The benefits of inhaled medication for the treatment of respiratory diseases are immense. Inhalers are unquestionably the most important medical devices for the treatment of asthma and in Europe today there are more than 230 different device and drug combinations of inhaled therapies many of which are available for the treatment of asthma. They are designed to alleviate the symptoms of asthma by controlling inflammation and minimizing exacerbations and are intended to be simple enough to operate by all patients regardless of their age and education. ⋯ The reality is that despite advances in the diagnosis of asthma, the availability of comprehensive asthma management guidelines and potent asthma medications combined with efficient delivery systems, uncontrolled disease is still linked to substantial morbidity and mortality. Despite the enormous benefits of delivering topically acting medication directly to the site of disease in the lungs adherence to treatment still remains one of the biggest challenges in asthma control. This current review looks at why patients have difficulty in using their inhalers and why adherence is so poor and how this may be improved through the use of innovation in inhaler design.